Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention 16 September
Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean 15 September
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines 08 September
